A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight
Completed · Phase 1
Conditions studied: Obesity, Overweight
In brief
The primary objective of this study is to evaluate the effect of a meal and evening dosing on the pharmacokinetics (PK) of KAI 7535 in healthy participants living with obesity or overweight.
Key facts
- Study ID
- NCT07294898
- Run by
- Kailera
- People needed
- 18
- Starts
- 2025-12-15
- Expected to finish
- 2026-01-26
- Last updated by the study team
- 2026-01-29
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Anaheim Clinical Trials — Anaheim, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.